Literature DB >> 24086947

Waldenstrom's macroglobulinemia presenting with lytic bone lesions: a rare presentation.

Mukta Pujani1, Shivani Kushwaha, Neha Sethi, Anu Beniwal, Shailaja Shukla.   

Abstract

Entities:  

Year:  2013        PMID: 24086947      PMCID: PMC3786287          DOI: 10.5045/br.2013.48.3.230

Source DB:  PubMed          Journal:  Blood Res        ISSN: 2287-979X


× No keyword cloud information.
  13 in total

Review 1.  Waldenström's macroglobulinemia: clinical features, complications, and management.

Authors:  M A Dimopoulos; P Panayiotidis; L A Moulopoulos; P Sfikakis; M Dalakas
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

Review 2.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Authors:  Roger G Owen; Steven P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesus F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

Review 3.  Waldenström's macroglobulinemia.

Authors:  M A Gertz; R Fonseca; S V Rajkumar
Journal:  Oncologist       Date:  2000

4.  Duodenal involvement in Waldenström's macroglobulinemia.

Authors:  A Gad; R Willén; B Carlén; F Gyland; M Wickander
Journal:  J Clin Gastroenterol       Date:  1995-03       Impact factor: 3.062

5.  Malignant lymphoma of the transverse colon associated with macroglobulinemia.

Authors:  O Yasui; F Tukamoto; N Sasaki; T Saito; H Yagisawa; A Uno; H Nanjo
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

6.  Clinicopathological correlates of IgM paraproteinemias.

Authors:  R G Owen; L A Parapia; J Higginson; S A Misbah; J A Child; G J Morgan; A S Jack
Journal:  Clin Lymphoma       Date:  2000-06

7.  Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.

Authors:  M A Dimopoulos; G Hamilos; K Zervas; A Symeonidis; G Kouvatseas; P Roussou; D Gika; T Karmiris; K Bourantas; A Zomas; C Mitsouli; I Xilouri; E Vervessou; K Matsis; N Anagnostopoulos; T Economopoulos
Journal:  Ann Oncol       Date:  2003-08       Impact factor: 32.976

Review 8.  Monoclonal macroglobulinemia with osteolytic lesions: a case report and review of the literature.

Authors:  L Leb; E T Grimes; K Balogh; J A Merritt
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

9.  Macroglobulinemia of Waldenström associated with severe osteolytic lesions.

Authors:  Y Krausz; A Zlotnick
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

10.  Bone scanning in Waldenstrom's macroglobulinemia.

Authors:  M A Marks; D E Tow; M Jay
Journal:  J Nucl Med       Date:  1985-12       Impact factor: 10.057

View more
  2 in total

1.  Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature.

Authors:  Mizba Baksh; Liuyan Jiang; Unnati Bhatia; Victoria Alegria; Taimur Sher; Vivek Roy; Asher Chanan-Khan; Sikander Ailawadhi; Ricardo D Parrondo
Journal:  Clin Case Rep       Date:  2021-12-07

2.  Does Waldenstrom's macroglobulinemia also cause bone destruction? A rare case report.

Authors:  Jun-Ming Lin; Xiao-Jun Yuan; Lu Zhang; Guang Li; Xin-Rong Gan; Wen-Hua Xu
Journal:  J Int Med Res       Date:  2022-04       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.